Taghizadeh, H., Unseld, M., Schmiderer, A., Djanani, A., Wilthoner, K., Buchinger, D., & Prager, G. W. (2020). First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer. Cancer Chemother Pharmacol.
Citação norma ChicagoTaghizadeh, Hossein, Matthias Unseld, Andreas Schmiderer, Angela Djanani, Klaus Wilthoner, Dieter Buchinger, and Gerald W. Prager. "First Evidence for the Antitumor Activity of Nanoliposomal Irinotecan With 5-fluorouracil and Folinic Acid in Metastatic Biliary Tract Cancer." Cancer Chemother Pharmacol 2020.
Citação norma MLATaghizadeh, Hossein, et al. "First Evidence for the Antitumor Activity of Nanoliposomal Irinotecan With 5-fluorouracil and Folinic Acid in Metastatic Biliary Tract Cancer." Cancer Chemother Pharmacol 2020.